IBDEI1K2 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24862,0)
 ;;=D47.4^^107^1211^182
 ;;^UTILITY(U,$J,358.3,24862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24862,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,24862,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,24862,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,24863,0)
 ;;=D59.1^^107^1211^29
 ;;^UTILITY(U,$J,358.3,24863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24863,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,24863,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,24863,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,24864,0)
 ;;=D51.3^^107^1211^196
 ;;^UTILITY(U,$J,358.3,24864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24864,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,24864,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,24864,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,24865,0)
 ;;=D77.^^107^1211^58
 ;;^UTILITY(U,$J,358.3,24865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24865,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,24865,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,24865,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,24866,0)
 ;;=D58.2^^107^1211^84
 ;;^UTILITY(U,$J,358.3,24866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24866,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,24866,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,24866,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,24867,0)
 ;;=C88.8^^107^1211^106
 ;;^UTILITY(U,$J,358.3,24867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24867,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,24867,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,24867,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,24868,0)
 ;;=D70.8^^107^1211^179
 ;;^UTILITY(U,$J,358.3,24868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24868,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,24868,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,24868,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,24869,0)
 ;;=D59.4^^107^1211^180
 ;;^UTILITY(U,$J,358.3,24869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24869,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,24869,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,24869,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,24870,0)
 ;;=D69.59^^107^1211^186
 ;;^UTILITY(U,$J,358.3,24870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24870,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,24870,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,24870,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,24871,0)
 ;;=C22.7^^107^1211^47
 ;;^UTILITY(U,$J,358.3,24871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24871,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,24871,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,24871,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,24872,0)
 ;;=D75.89^^107^1211^57
 ;;^UTILITY(U,$J,358.3,24872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24872,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,24872,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,24872,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,24873,0)
 ;;=D47.Z9^^107^1211^178
 ;;^UTILITY(U,$J,358.3,24873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24873,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,24873,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,24873,2)
 ;;=^5002262
